Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers

scientific article published on 01 March 1997

Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0002-9610(97)89589-X
P698PubMed publication ID9124619

P2093author name stringM Mendes
C Aniceto
F M Jesus
R Marques da Costa
P2860cites workNovel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healingQ36231441
Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cellsQ36357544
Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulnessQ38140276
Cutaneous tissue repair: basic biologic considerations. I.Q38156179
Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growthQ43891202
Angiogenesis in wound healingQ67715056
Local peri-lesional therapy with rhGM-CSF for Kaposi's sarcomaQ72217460
Treatment of non-healing ulcers with rhGM-CSF and skin graftsQ72674997
Quick healing of leg ulcers after molgramostimQ72687958
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectmacrophageQ184204
placeboQ269829
placebo-controlled trialQ108853737
P304page(s)165-168
P577publication date1997-03-01
P1433published inThe American Journal of SurgeryQ15762745
P1476titleDouble-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers
P478volume173